<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>EVIDENCE 08 :: LAB EQUIPMENT LOGS</title>
    <link href="https://fonts.googleapis.com/css2?family=Orbitron:wght@400;700;900&family=Rajdhani:wght@300;400;600;700&family=Share+Tech+Mono&display=swap" rel="stylesheet">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { background: #050814; color: #00f7ff; font-family: 'Rajdhani', sans-serif; min-height: 100vh; padding: 20px; }
        body::before { content: ''; position: fixed; top: 0; left: 0; width: 100%; height: 100%; background: repeating-linear-gradient(0deg, rgba(0, 247, 255, 0.03) 0px, transparent 1px, transparent 2px, rgba(0, 247, 255, 0.03) 3px); pointer-events: none; animation: scanlines 8s linear infinite; z-index: 1; }
        @keyframes scanlines { 0% { transform: translateY(0); } 100% { transform: translateY(10px); } }
        .container { max-width: 1200px; margin: 0 auto; background: rgba(5, 8, 20, 0.95); border: 2px solid #00f7ff; padding: 40px; position: relative; z-index: 2; box-shadow: 0 0 40px rgba(0, 247, 255, 0.3); }
        .header { text-align: center; margin-bottom: 30px; padding-bottom: 20px; border-bottom: 2px solid #ff006e; }
        h1 { font-family: 'Orbitron', sans-serif; color: #ff006e; font-size: 32px; margin-bottom: 10px; text-shadow: 0 0 20px rgba(255, 0, 110, 0.8); }
        .evidence-number { font-family: 'Share Tech Mono', monospace; color: #ffd700; font-size: 14px; letter-spacing: 2px; }
        .info-box { background: rgba(255, 215, 0, 0.1); border-left: 4px solid #ffd700; padding: 15px 20px; margin: 20px 0; font-family: 'Share Tech Mono', monospace; font-size: 13px; }
        .section { margin: 30px 0; }
        .section-title { font-family: 'Orbitron', sans-serif; color: #ffd700; font-size: 20px; margin-bottom: 20px; text-transform: uppercase; letter-spacing: 2px; border-bottom: 2px solid #00f7ff; padding-bottom: 10px; }
        .log-table { width: 100%; border-collapse: collapse; margin: 20px 0; font-family: 'Share Tech Mono', monospace; font-size: 12px; }
        .log-table th { background: rgba(255, 215, 0, 0.2); color: #ffd700; padding: 12px 8px; text-align: left; border-bottom: 2px solid #ffd700; }
        .log-table td { padding: 10px 8px; border-bottom: 1px solid rgba(0, 247, 255, 0.2); color: #00f7ff; }
        .log-table tr:hover { background: rgba(0, 247, 255, 0.1); }
        .flagged { background: rgba(255, 0, 110, 0.2); }
        .suspicious { background: rgba(255, 215, 0, 0.2); }
        .note { background: rgba(255, 0, 110, 0.1); border-left: 3px solid #ff006e; padding: 15px; margin: 20px 0; font-size: 14px; }
        .note-title { color: #ff006e; font-weight: bold; margin-bottom: 8px; }
        .back-link { display: inline-block; margin-top: 30px; padding: 12px 24px; background: rgba(0, 247, 255, 0.2); border: 1px solid #00f7ff; color: #00f7ff; text-decoration: none; font-family: 'Share Tech Mono', monospace; transition: all 0.3s ease; text-transform: uppercase; letter-spacing: 1px; }
        .back-link:hover { background: #00f7ff; color: #050814; box-shadow: 0 0 20px rgba(0, 247, 255, 0.6); }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>LAB EQUIPMENT LOGS</h1>
            <div class="evidence-number">EVIDENCE FILE #08 :: CASE #2847-NGT</div>
        </div>

        <div class="info-box">
            <strong>SOURCE:</strong> NGT Equipment Management System (Secure Logs)<br>
            <strong>LOCATION:</strong> Floor 43, Medical Division - CRISPR Synthesis Lab<br>
            <strong>DATE RANGE:</strong> November 19-23, 2084<br>
            <strong>EQUIPMENT:</strong> CRISPR-Gen 9000 Automated Synthesis Station<br>
            <strong>CLEARANCE REQUIRED:</strong> ALPHA level or higher
        </div>

        <div class="section">
            <div class="section-title">CRISPR Synthesis Equipment - Usage Logs</div>

            <table class="log-table">
                <thead>
                    <tr>
                        <th>DATE</th>
                        <th>TIME</th>
                        <th>USER ID</th>
                        <th>USER NAME</th>
                        <th>DURATION</th>
                        <th>PROJECT CODE</th>
                        <th>SAMPLES CREATED</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Nov 19</td>
                        <td>14:22</td>
                        <td>NGT-0523</td>
                        <td>Volkov, Elena</td>
                        <td>4h 17m</td>
                        <td>HELIX-2084-V7</td>
                        <td>12 research samples</td>
                    </tr>
                    <tr class="flagged">
                        <td>Nov 20</td>
                        <td>09:15</td>
                        <td>NGT-0892</td>
                        <td>Foster, Raymond</td>
                        <td>2h 43m</td>
                        <td>MED-PREP-STD</td>
                        <td>3 medical doses</td>
                    </tr>
                    <tr>
                        <td>Nov 20</td>
                        <td>16:30</td>
                        <td>NGT-0523</td>
                        <td>Volkov, Elena</td>
                        <td>3h 55m</td>
                        <td>HELIX-2084-V8</td>
                        <td>8 research samples</td>
                    </tr>
                    <tr class="flagged">
                        <td>Nov 21</td>
                        <td>08:00</td>
                        <td>NGT-0892</td>
                        <td>Foster, Raymond</td>
                        <td>5h 12m</td>
                        <td>MED-EXEC-Y-1123</td>
                        <td>1 executive therapy dose</td>
                    </tr>
                    <tr class="suspicious">
                        <td>Nov 21</td>
                        <td>11:30</td>
                        <td>NGT-0523</td>
                        <td>Volkov, Elena</td>
                        <td>-</td>
                        <td>-</td>
                        <td>Door access only (no equipment login)</td>
                    </tr>
                    <tr>
                        <td>Nov 21</td>
                        <td>19:45</td>
                        <td>NGT-0523</td>
                        <td>Volkov, Elena</td>
                        <td>1h 22m</td>
                        <td>HELIX-2084-V9</td>
                        <td>4 research samples</td>
                    </tr>
                    <tr>
                        <td>Nov 22</td>
                        <td>11:30</td>
                        <td>NGT-0892</td>
                        <td>Foster, Raymond</td>
                        <td>1h 08m</td>
                        <td>MED-PREP-STD</td>
                        <td>2 medical doses</td>
                    </tr>
                </tbody>
            </table>

            <div class="note">
                <div class="note-title">üéØ CRITICAL FINDING - NOVEMBER 21:</div>
                Dr. Foster logged a 5-hour session creating "1 executive therapy dose" - this is Dr. Yamamoto's gene therapy ampule (project code MED-EXEC-Y-1123 matches victim initials and date).<br><br>
                At 11:30 during Foster's session, Dr. Volkov accessed the synthesis lab but did NOT log into the equipment. Witness testimony confirms she had a private 20-minute conversation with Foster in this room.<br><br>
                <strong>SMOKING GUN:</strong> This proves both Foster AND Volkov were present when Yamamoto's dose was being prepared. The toxin could have been added during this window with both scientists collaborating.
            </div>
        </div>

        <div class="section">
            <div class="section-title">Secure Storage Access - Gene Therapy Vault</div>

            <table class="log-table">
                <thead>
                    <tr>
                        <th>DATE</th>
                        <th>TIME</th>
                        <th>USER</th>
                        <th>ACTION</th>
                        <th>ITEM ACCESSED</th>
                    </tr>
                </thead>
                <tbody>
                    <tr class="flagged">
                        <td>Nov 21</td>
                        <td>13:08</td>
                        <td>Foster, Raymond</td>
                        <td>DEPOSIT</td>
                        <td>Ampule MED-EXEC-Y-1123 (Yamamoto dose)</td>
                    </tr>
                    <tr>
                        <td>Nov 22</td>
                        <td>08:52</td>
                        <td>Tanaka, Yuki</td>
                        <td>WITHDRAWAL</td>
                        <td>Ampule MED-EXEC-Y-1123 (for delivery)</td>
                    </tr>
                    <tr>
                        <td>Nov 22</td>
                        <td>09:03</td>
                        <td>Tanaka, Yuki</td>
                        <td>DEPOSIT</td>
                        <td>Ampule MED-EXEC-Y-1123 (to Lab 12-A refrigeration)</td>
                    </tr>
                    <tr class="flagged">
                        <td>Nov 23</td>
                        <td>22:18</td>
                        <td>Tanaka, Yuki</td>
                        <td>WITHDRAWAL</td>
                        <td>Ampule MED-EXEC-Y-1123 (final delivery to victim)</td>
                    </tr>
                </tbody>
            </table>

            <div class="note">
                <div class="note-title">CHAIN OF CUSTODY:</div>
                The poisoned ampule was created by Foster on Nov 21, stored in secure vault same day. Tanaka retrieved it Nov 22 and placed it in Lab 12-A refrigeration (where Yamamoto accessed his daily doses). On Nov 23, Tanaka delivered it for final administration.<br><br>
                The ampule was never out of secure storage except when handled by authorized personnel. This rules out external tampering - the toxin was built into the dose during preparation.
            </div>
        </div>

        <div class="section">
            <div class="section-title">Genetic Database Access Logs</div>

            <table class="log-table">
                <thead>
                    <tr>
                        <th>DATE</th>
                        <th>TIME</th>
                        <th>USER</th>
                        <th>FILE ACCESSED</th>
                        <th>PURPOSE</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Nov 17</td>
                        <td>10:22</td>
                        <td>Foster, Raymond</td>
                        <td>Yamamoto genetic profile</td>
                        <td>Medical review (authorized)</td>
                    </tr>
                    <tr class="flagged">
                        <td>Nov 19</td>
                        <td>16:47</td>
                        <td>Volkov, Elena</td>
                        <td>Yamamoto genetic profile</td>
                        <td>Research comparison (authorized)</td>
                    </tr>
                    <tr>
                        <td>Nov 20</td>
                        <td>09:33</td>
                        <td>Tanaka, Yuki</td>
                        <td>Yamamoto genetic profile</td>
                        <td>Lab prep (authorized by Yamamoto)</td>
                    </tr>
                </tbody>
            </table>

            <div class="note">
                <div class="note-title">GENETIC ACCESS ANALYSIS:</div>
                All three individuals (Foster, Volkov, Tanaka) accessed Yamamoto's complete genetic sequence in the week before the murder. However:<br><br>
                ‚Ä¢ Foster had medical necessity<br>
                ‚Ä¢ Tanaka's access was routine for lab work<br>
                ‚Ä¢ Volkov's "research comparison" access is suspicious - she had no active project requiring Yamamoto's genetic data<br><br>
                The toxin required Yamamoto's specific SCN5A gene polymorphism data. Volkov accessing this information 2 days before Foster prepared the dose suggests she provided the targeting specifications.
            </div>
        </div>

        <div class="section">
            <div class="section-title">Medical Refrigeration Unit - Lab 12-A</div>

            <table class="log-table">
                <thead>
                    <tr>
                        <th>DATE</th>
                        <th>TIME</th>
                        <th>USER</th>
                        <th>ACTION</th>
                        <th>NOTES</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Nov 22</td>
                        <td>09:03</td>
                        <td>Tanaka, Yuki</td>
                        <td>DEPOSIT</td>
                        <td>Yamamoto weekly supply placed in unit</td>
                    </tr>
                    <tr>
                        <td>Nov 23</td>
                        <td>22:18</td>
                        <td>Tanaka, Yuki</td>
                        <td>WITHDRAWAL</td>
                        <td>Retrieved dose for immediate delivery</td>
                    </tr>
                    <tr class="flagged">
                        <td>Nov 23</td>
                        <td>22:30</td>
                        <td>Yamamoto, Kenji</td>
                        <td>CONSUMPTION</td>
                        <td>Auto-injector administered 3.2ml dose</td>
                    </tr>
                </tbody>
            </table>

            <div class="note">
                <div class="note-title">FINAL CHAIN OF EVIDENCE:</div>
                The refrigeration unit logs prove the ampule was in secure storage from Nov 22 (09:03) until Nov 23 (22:18) when Tanaka retrieved it for delivery. The unit is biometrically locked - only Yamamoto and Tanaka had access. No tampering possible during storage period.
            </div>
        </div>

        <div style="background: rgba(255, 0, 110, 0.15); padding: 25px; margin: 30px 0; border: 2px solid #ff006e;">
            <strong style="color: #ff006e; font-size: 20px;">EQUIPMENT LOG CONCLUSIONS:</strong><br><br>

            <strong>1. CONSPIRACY CONFIRMED:</strong> Foster prepared the dose, but Volkov was present during preparation (Nov 21, 11:30) for a 20-minute private conversation. Both had accessed Yamamoto's genetic profile beforehand.<br><br>

            <strong>2. TOXIN PREPARATION:</strong> The poison was integrated during Foster's 5-hour synthesis session on Nov 21. Volkov likely provided the genetic targeting specifications (she accessed the profile Nov 19).<br><br>

            <strong>3. TANAKA'S INNOCENCE:</strong> She handled the ampule according to routine procedures. No evidence she knew it contained a toxin. She was following standard protocol.<br><br>

            <strong>4. SECURE CHAIN OF CUSTODY:</strong> The ampule never left secure storage except when handled by authorized personnel. External tampering impossible. The murder was an inside job requiring ALPHA-level access.<br><br>

            <strong style="color: #ffd700;">FINAL ANALYSIS:</strong> Equipment logs prove Volkov and Foster collaborated to create the toxin on Nov 21. Chen paid Tanaka ¬•8.5M to unwittingly deliver it. Armstrong provided security coverage and alibis. This is a FOUR-PERSON CONSPIRACY.
        </div>

        <div style="text-align: center; margin-top: 40px;">
            <a href="index.html" class="back-link">‚Üê Return to Investigation Hub</a>
        </div>
    </div>
</body>
</html>
